BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BIOTECanada - ECPv6.6.4.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BIOTECanada
X-ORIGINAL-URL:https://www.biotech.ca
X-WR-CALDESC:Events for BIOTECanada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20261110T080000
DTEND;TZID=America/Toronto:20270505T170000
DTSTAMP:20261121T071004
CREATED:20260820T175709Z
LAST-MODIFIED:20260820T175709Z
UID:10000535-1794297600-1809536400@www.biotech.ca
SUMMARY:Canada–Chicago Mentoring Program (C2MP)
DESCRIPTION:Join the Canada–Chicago Mentoring Program to accelerate your global business growth! \nIs your life science or healthcare company seeking to gain traction in the United States? \nThe Canada–Chicago Mentoring Program (C2MP) is back! The Trade Commissioner Service (TCS)\, in partnership with MATTER\, Chicago’s leading healthcare and life sciences incubator\, is offering Canadian start‑ups a unique chance to sharpen their go‑to‑market strategy and build a strong U.S. presence. \nOver a 6‑month hybrid accelerator program (November 10\, 2026 – May 5\, 2027)\, 5 selected Canadian companies will receive strategic mentoring and guidance from experienced U.S. industry leaders. \nSuccessful applicants will take part in a virtual day of acceleration\, monthly mentoring sessions\, educational workshops\, and an in‑person pitch event in Chicago at the program’s conclusion. \nDates: November 10\, 2026 to May 5\, 2027\nLocation: Virtual and in person at MATTER Healthcare Incubator in Chicago\, United States \nCheck C2MP alumni and apply for the program to position your company for success in the U.S. healthcare market. \npromotion brochure and the application form to be returned completed to julien.rosan@international.gc.ca by August 31\, 2026 \nC2MP 2027 Promotion Brochure\nC2MP 2027 Application \n—- \nRejoignez le programme de mentorat Canada–Chicago pour accélérer la croissance de votre entreprise à l’échelle mondiale! \nVotre entreprise de sciences de la vie ou de soins de santé souhaite‑t‑elle accroître sa présence aux États‑Unis? \nLe Programme de mentorat Canada–Chicago (C2MP) est de retour! Le Service des délégués commerciaux (SDC)\, en partenariat avec MATTER\, l’incubateur de premier plan de Chicago dans le domaine des sciences de la vie et des soins de santé\, offre aux jeunes entreprises canadiennes une occasion unique d’affiner leur stratégie de mise en marché et de renforcer leur présence aux États‑Unis. \nAu cours d’un programme hybride de 6 mois (du 10 novembre 2026 au 5 mai 2027)\, 5 entreprises canadiennes sélectionnées bénéficieront de conseils stratégiques et d’un accompagnement de la part de chefs de file américains du secteur. \nLes entreprises retenues participeront à une journée d’accélération virtuelle\, à des séances mensuelles de mentorat\, à des ateliers de formation\, ainsi qu’à une présentation en personne à Chicago à la fin du programme. \nDates : du 10 novembre 2026 au 5 mai 2027\nLieu : En ligne et en personne chez MATTER Healthcare Incubator à Chicago\, aux États‑Unis \nConsultez les anciens participants au C2MP (en anglais seulement) et posez votre candidature afin positionner votre entreprise en vue d’une réussite sur le marché américain des soins de santé. \nla brochure de promotion et le formulaire de candidature à retourner complété à julien.rosan@international.gc.ca d’ici le 31 août 2026. \nC2MP 2027 Promotion Brochure\nC2MP 2027 Application \n 
URL:https://www.biotech.ca/event/canada-chicago-mentoring-program-c2mp/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20261125T120000
DTEND;TZID=America/Toronto:20261125T130000
DTSTAMP:20261121T071005
CREATED:20261117T201247Z
LAST-MODIFIED:20261117T201247Z
UID:10000549-1795608000-1795611600@www.biotech.ca
SUMMARY:Ayming Webinar - Biotech: what Federal Budget 2026 means for SR&ED\, IP costs and funding through long development cycles
DESCRIPTION:What is it\nFederal Budget 2026 adds regulatory testing and IP protection costs to SR&ED\, backed by $930 million over five years. BIOTECanada members are invited to hear Ayming Canada’s specialists explain what it means for biotech companies. \nThis is Ayming’s own analysis\, not a recap of the government’s budget: what matters\, what is still unclear\, and a 90-day action plan. Ayming’s funding and tax specialists will cover the measures that matter for companies with long development timelines and share a 90-day plan. \nWhat members will take away\n\nSR&ED changes: which regulatory testing\, certification and IP protection costs may qualify\, and how to start documenting them. For calendar-year companies\, the change applies from January 1\, 2027.\nEquipment and facilities: how the Productivity Mega Deduction could affect lab and manufacturing investments\, and the open question on intangible assets.\nA 90-day plan: the first moves to make before year-end\, in the order Ayming would make them.\n\nFirst access for registrants: everyone who registers receives first access to Ayming’s Federal Budget 2026 report. \nAbout Ayming Canada\nAyming Canada helps businesses secure SR&ED tax credits\, government funding and innovation incentives. With 40 years of expertise in government funding and tax incentives\, Ayming helps you engineer your projects and secure the financial support you need to grow and innovate. Pioneers in Canada\, they were the first consulting firm to establish a national grant practice dedicated to maximizing public funding opportunities. They secure $1.5 billion annually in funding for their clients\, achieving a 98.5% success rate on claims submitted. With flexible engagement models and end-to-end support\, from identifying opportunities to managing claims\, they act as an extension of your team\, maximizing results.
URL:https://www.biotech.ca/event/ayming-webinar-biotech-what-federal-budget-2026-means-for-sred-ip-costs-and-funding-through-long-development-cycles/
CATEGORIES:Member Event,Webinar
END:VEVENT
END:VCALENDAR